OBJECTIVE: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. METHODS AND RESULTS: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT(h/h) or ApoeR(h/h)mice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR(h/h) mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT(h/h) mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR(h/h) macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. CONCLUSIONS: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.
OBJECTIVE:Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. METHODS AND RESULTS: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT(h/h) or ApoeR(h/h)mice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR(h/h) mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT(h/h) mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR(h/h) macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules. CONCLUSIONS: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.
Authors: Anna M Bennet; Emanuele Di Angelantonio; Zheng Ye; Frances Wensley; Anette Dahlin; Anders Ahlbom; Bernard Keavney; Rory Collins; Björn Wiman; Ulf de Faire; John Danesh Journal: JAMA Date: 2007-09-19 Impact factor: 56.272
Authors: Julie A Morrow; Danny M Hatters; Bin Lu; Peter Hochtl; Keith A Oberg; Bernhard Rupp; Karl H Weisgraber Journal: J Biol Chem Date: 2002-10-21 Impact factor: 5.157
Authors: Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese Journal: Atherosclerosis Date: 2018-08-30 Impact factor: 5.162
Authors: Nathalie Gaudreault; Nikit Kumar; Victor R Olivas; Delphine Eberlé; Kyle Stephens; Robert L Raffai Journal: Am J Pathol Date: 2013-10-08 Impact factor: 4.307
Authors: James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui Journal: J Biol Chem Date: 2012-06-23 Impact factor: 5.157
Authors: Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai Journal: J Cardiovasc Pharmacol Date: 2016-01 Impact factor: 3.105
Authors: Emily J Koller; Elsa Gonzalez De La Cruz; Mary Weinrich; Tosha Williams; Pedro E Cruz; Daniel Ryu; Todd E Golde; Patrick M Sullivan; Jada Lewis; David R Borchelt; Paramita Chakrabarty Journal: Mol Neurobiol Date: 2020-01-06 Impact factor: 5.590
Authors: David Nguyen; Padmaja Dhanasekaran; Margaret Nickel; Chiharu Mizuguchi; Mayu Watanabe; Hiroyuki Saito; Michael C Phillips; Sissel Lund-Katz Journal: Biochemistry Date: 2014-06-24 Impact factor: 3.162
Authors: Victoria Ulrich; Eddy S Konaniah; Joachim Herz; Robert D Gerard; Eunjeong Jung; Ivan S Yuhanna; Mohamed Ahmed; David Y Hui; Chieko Mineo; Philip W Shaul Journal: Proc Natl Acad Sci U S A Date: 2014-09-02 Impact factor: 11.205